Summary
DxTerity Diagnostics Inc (DxTerity) is a medical device company that offers molecular diagnostic solutions. The company develops genomic tests for disease diagnosis. Its patient clinical research platform and dxcollect fingerstick collection kit are used for population-scale genomic studies. The company's dxdirect technology facilitates the direct blood testing of RNA and DNA. DxTerity's blood-based genomic tests include radiation exposure dosage index test, radiation toxicity test, and rheumatoid arthritis test. It also offers a curation of bioinformatics databases and analysis of RNA and DNA sequence data. DxTerity is headquartered in Rancho Dominguez, California, the US.
This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
DxTerity Diagnostics Inc (DxTerity) is a medical device company that offers molecular diagnostic solutions. The company develops genomic tests for disease diagnosis. Its patient clinical research platform and dxcollect fingerstick collection kit are used for population-scale genomic studies. The company's dxdirect technology facilitates the direct blood testing of RNA and DNA. DxTerity's blood-based genomic tests include radiation exposure dosage index test, radiation toxicity test, and rheumatoid arthritis test. It also offers a curation of bioinformatics databases and analysis of RNA and DNA sequence data. DxTerity is headquartered in Rancho Dominguez, California, the US.
This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company DxTerity Diagnostics Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- DxTerity Diagnostics Inc Company Overview
- DxTerity Diagnostics Inc Company Snapshot
- DxTerity Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview
- DxTerity Diagnostics Inc - Pipeline Analysis Overview
- DxTerity Diagnostics Inc - Key Facts
- DxTerity Diagnostics Inc - Major Products and Services
- DxTerity Diagnostics Inc Pipeline Products by Development Stage
- DxTerity Diagnostics Inc Ongoing Clinical Trials by Trial Status
- DxTerity Diagnostics Inc Pipeline Products Overview
- Autoimmune Profile Test - Multiple Sclerosis
- Autoimmune Profile Test - Multiple Sclerosis Product Overview
- DxCollect MicroCollection Tube
- DxCollect MicroCollection Tube Product Overview
- DxCollect MicroCollection Tube Clinical Trial
- Dxterity Kit - RA
- Dxterity Kit - RA Product Overview
- RadTox Test
- RadTox Test Product Overview
- REDI-Dx High Throughput Radiation Biodosimetry Test System
- REDI-Dx High Throughput Radiation Biodosimetry Test System Product Overview
- DxTerity Diagnostics Inc - Key Competitors
- DxTerity Diagnostics Inc - Key Employees
- DxTerity Diagnostics Inc - Locations And Subsidiaries
- Head Office
- Recent Developments
- DxTerity Diagnostics Inc, Recent Developments
- Nov 08, 2021: DxTerity Diagnostics announces its OSHA Emergency Temporary Standard (ETS) Compliance-Ready COVID-19 Employer Screening Service
- Oct 05, 2020: Hematogenix unites with 19 organizations from the healthcare community to form COVID-19 testing industry consortium
- Oct 01, 2020: 19 Organizations from the healthcare community unite to form COVID-19 testing Industry Consortium
- Mar 03, 2020: DxTerity receives CE Mark for DxCollect fingerstick blood RNA stabilization device
- Oct 21, 2018: DxTerity announces presentations from lupus and multiple sclerosis studies at the 2018 ACR/ARHP Annual Meeting
- Jun 07, 2018: DxTerity Announces Preliminary Results from the LIFT Study will be Presented at the 2018 Annual European Congress of Rheumatology
- May 29, 2018: DxTerity Diagnostics Receives CE Mark for the REDI-Dx Radiation Biodosimetry Test
- Nov 05, 2017: DxTerity Announces Preliminary Results from the BRAVO Study will be Presented at the 2017 ACR/ARHP Annual Meeting
- Oct 04, 2016: DxTerity Diagnostics Awarded Up to $150 Million BARDA Contract for Advanced Development and Delivery of REDI-Dx® High Throughput Radiation Biodosimetry Test
- Dec 20, 2013: DxTerity’s REDI-Dx Wins 2013 NCT CBRNe Product of the Year Award
- Appendix
- Methodology
- About the Analyst
- Contact the Analyst
- Disclaimer
- DxTerity Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview
- DxTerity Diagnostics Inc Pipeline Products by Equipment Type
- DxTerity Diagnostics Inc Pipeline Products by Indication
- DxTerity Diagnostics Inc Ongoing Clinical Trials by Trial Status
- DxTerity Diagnostics Inc, Key Facts
- DxTerity Diagnostics Inc, Major Products and Services
- DxTerity Diagnostics Inc Number of Pipeline Products by Development Stage
- DxTerity Diagnostics Inc Pipeline Products Summary by Development Stage
- DxTerity Diagnostics Inc Ongoing Clinical Trials by Trial Status
- DxTerity Diagnostics Inc Ongoing Clinical Trials Summary
- Autoimmune Profile Test - Multiple Sclerosis - Product Status
- Autoimmune Profile Test - Multiple Sclerosis - Product Description
- DxCollect MicroCollection Tube - Product Status
- DxCollect MicroCollection Tube - Product Description
- DxCollect MicroCollection Tube - BRAVO (Baseline Rheumatoid Arthritis Verification Outcomes)
- Dxterity Kit - RA - Product Status
- Dxterity Kit - RA - Product Description
- RadTox Test - Product Status
- RadTox Test - Product Description
- REDI-Dx High Throughput Radiation Biodosimetry Test System - Product Status
- REDI-Dx High Throughput Radiation Biodosimetry Test System - Product Description
- DxTerity Diagnostics Inc, Key Employees
- Glossary
- DxTerity Diagnostics Inc Pipeline Products by Equipment Type
- DxTerity Diagnostics Inc Pipeline Products by Development Stage
- DxTerity Diagnostics Inc Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- MedGenome Inc.
- Pathway Genomics Corp
- LungLife AI Inc
